Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00735670 · ClinicalTrials.gov registry record · NA

Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury

A NA study of Spinal Cord Injury, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT00735670 is a NA study of Spinal Cord Injury that has completed, run by University of Michigan. The registered enrollment target is 34 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00735670, a NA study of Spinal Cord Injury, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

This study was initially designed to test the efficacy of Venlafaxine HCl in reducing incidence of the onset of major depression after a new spinal cord injury (SCI). After several protocol modifications, the purpose of the study is to test the effectiveness of a sub-therapeutic dose of Venlafaxine HCl to reduce mild to moderate symptoms in persons with SCI.

Conditions Studied

Interventions

  • OTHER Placebo
  • DRUG Venlafaxine HCl

Study Locations (1)

Michigan

  • University of Michigan Model SCI Care System - Ann Arbor

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2008-06
Est. Completion 2012-08
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT00735670

The ClinicalTrials.gov registry entry for NCT00735670 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (60% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00735670 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT00735670 about?

NCT00735670 is a clinical study titled "Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury". This study was initially designed to test the efficacy of Venlafaxine HCl in reducing incidence of the onset of major depression after a new spinal cord injury (SCI). After several protocol modifications, the purpose of the study is to test the effectiveness of a sub-therapeutic dose of Venlafaxine ...

What is the current status of trial NCT00735670?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2008-06. Estimated completion is 2012-08.

What conditions does trial NCT00735670 study?

This clinical trial studies the following conditions: Spinal Cord Injury.

What interventions are being tested in trial NCT00735670?

The interventions under investigation include: Placebo (OTHER), Venlafaxine HCl (DRUG).

Who is sponsoring clinical trial NCT00735670?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00735670 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.